Applicant, as named in the Orange Book

Ascendis

Next listed expiry: Yuviwel on 12 Nov 2042. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Yuviwel · 3 strengths navepegritide	navepegritide	219164	12 Nov 2042	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.